Alternative to Warfarin for Arrhythmia Winston Salem NC

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study. Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity.

Kenneth B Rhinehart, MD
(336) 722-0449
3171 Flanders Dr
Winston Salem, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Washington Univ Sch Of Med, St Louis Mo 63110
Graduation Year: 1978

Data Provided by:
James Patrick Holland
(336) 768-0437
3073 Trenwest Dr
Winston-Salem, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Gretchen Lois Wells, MD
(336) 716-9664
Medical Center Blvd,
Winston Salem, NC
Specialties
Cardiology
Gender
Female
Education
Medical School: Univ Of Al Sch Of Med, Birmingham Al 35294
Graduation Year: 1994

Data Provided by:
Dalane Kitzman
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Behzad Taghizadeh
(336) 765-2500
150 Charlois Blvd
Winston Salem, NC
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Rahul Aggarwal, MD
(336) 771-2205
4940 Bridgton Place Dr
Winston Salem, NC
Specialties
Cardiology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
David Mc Leod Herrington, MD
(336) 716-9124
Medical Center Blvd,
Winston Salem, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1983

Data Provided by:
Karen Hazel Raines, MD
(336) 716-4627
Winston-Salem, NC
Specialties
Cardiology
Gender
Female
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1984

Data Provided by:
Theodore Allen Keith, MD
(336) 277-1700
3073 Trenwest Dr
Winston Salem, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1967

Data Provided by:
Walter Curtis Pearcy, MD
3073 Trenwest Dr
Winston Salem, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Sc Sch Of Med, Columbia Sc 29208
Graduation Year: 1987

Data Provided by:
Data Provided by:

Alternative to Warfarin for Arrhythmia

Provided By:

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study.

Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity. More than 90 percent of atrial blood clots in people with non-valvular atrial fibrillation may originate in the LAA, according to background information in the study.

The study included 463 people who underwent percutaneous implantation of a device, known as the Watchman, to close off the LAA. Their outcomes were compared with those of 244 people who continued long-term treatment with warfarin.

The researchers determined the effectiveness of the treatments by assessing the occurrence, during an average follow-up of 18 months, of strokes, death from cardiovascular causes and systemic embolisms (blood clots that go somewhere other than the brain). They also totaled the occurrence of such serious problems as major bleeding, pericardial effusion (accidental puncture of the heart causing fluid collection in the heart sac) and clots caused by the implanted device.

After 1,065 patient-years of follow-up, there were 3.0 such occurrences per 100 patient-years among those who'd had the device implanted, compared with 4.9 in the warfarin group, for a risk reduction of 38 percent. But people in the device group had more serious safety events -- 7.4 events per 100 patient-years versus 4.4 events in the warfarin group, the researchers found.

"The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy," concluded Dr. David R. Holmes, of the Mayo Clinic in Rochester, Minn., and his colleagues. "Although there was a higher rate of adverse safety events in the intervention group than the control group, events in the intervention group were mainly a result of periprocedural complications," they wrote.

"Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation," they added.

The study appears this week in The Lancet.

More information

The American Academy of Family Physicians has more about atrial fibrillation.

SOURCE: The Lancet, news release, Aug. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com